Supplemental material
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume 20, 2019 - Issue 3-4
Research Article
A standard operating procedure for King’s ALS clinical staging
, , & 
Ammar Al-ChalabiDepartment of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, UKCorrespondence[email protected]
http://orcid.org/0000-0002-4924-7712View further author information
http://orcid.org/0000-0002-4924-7712View further author informationRelated Research Data
Limits of agreement (Bland-Altman method).
Source:
BMJ
Prevalence and patterns of cognitive impairment in sporadic ALS.
Source:
Ovid Technologies (Wolters Kluwer Health)
Association between estimated total daily energy expenditure and stage of amyotrophic lateral sclerosis.
Source:
Elsevier BV
Statistical methods for assessing agreement between two methods of clinical measurement.
Source:
Elsevier BV
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)
Source:
BMJ Publishing Group
Comparison of slow and forced vital capacities on ability to predict survival in ALS.
Source:
Informa UK Limited
Socioeconomic costs of amyotrophic lateral sclerosis according to staging system
Source:
Informa UK Limited
Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis
Source:
Elsevier BV
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study
Source:
Wiley
Neurofilament Light Chain Levels in Definite Subtypes of Disease
Source:
American Medical Association (AMA)
Linking provided by
